Apollomics APLM
NASDAQ APLM
$23.86 -1.02 (-4.04%)
As of: Sep 10, 2026 · 11:04 AM EDT

Apollomics (APLM) Current Leases (2021 - 2025)

Apollomics' (APLM) quarterly Current Leases came in at $209000.0 in Q4 2025, down 10.3% year-over-year from $233000.0 in Q4 2024, and up 2.96% quarter-over-quarter from $203000.0 in Q2 2025.

Analysis

Apollomics (APLM) Current Leases (2021 - 2025) Analysis & Trends

Apollomics (APLM) has reported Current Leases for 5 consecutive years, with $209000.0 the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Current Leases fell 10.3% year-over-year to $209000.0 in Q4 2025; TTM through Dec 2025 was $209000.0, a 10.3% decrease from a year earlier, with the FY2025 full-year figure at $209000.0, down 10.3% from the prior year.
  • Current Leases was $209000.0 for Q4 2025 at Apollomics, up from $203000.0 in the prior quarter.
  • Over five years, Current Leases peaked at $6.3 million in Q4 2021 and troughed at $158000.0 in Q4 2023.
  • A 5-year average of $1.0 million and a median of $248500.0 in 2024 frame the typical range for Current Leases.
  • Across the five-year window, Current Leases tumbled 90.31% in 2022 and jumped 47.47% in 2024, its largest moves.
  • Over 5 years, Current Leases stood at $6.3 million in 2021, then plunged by 90.31% to $614000.0 in 2022, then tumbled by 74.27% to $158000.0 in 2023, then surged by 47.47% to $233000.0 in 2024, then dropped by 10.3% to $209000.0 in 2025.
  • The last three Current Leases figures came in at $209000.0 (Q4 2025), $203000.0 (Q2 2025), and $233000.0 (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 720.00 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 11.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 45.93 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 12.38 Mn
10 Apollomics 34.50 Mn 31.23 Mn - 209,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 209,000.00
Jun 30, 2025 203,000.00
Dec 31, 2024 233,000.00
Jun 30, 2024 264,000.00
Dec 31, 2023 158,000.00
Jun 30, 2023 294,000.00
Dec 31, 2022 614,000.00
Dec 31, 2021 6.34 Mn